{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:00:12Z","timestamp":1789124412053,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"am","delay-in-days":398,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0012"],"award-info":[{"award-number":["ANR-18-RHUS-0012"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011963","name":"European Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008052","name":"Fundaci\u00f3n Alfonso Mart\u00edn Escudero","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neurol.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T08:32:30Z","timestamp":1703233950000},"page":"107-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes"],"prefix":"10.1016","volume":"180","author":[{"given":"M.","family":"Villagr\u00e1n-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Campetella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Arzalluz-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2023.12.001_bib0415","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1212\/CON.0000000000000817","article-title":"Physiology and pathophysiology of the autonomic nervous system","volume":"26","author":"Benarroch","year":"2020","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0420","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrneurol.2014.88","article-title":"The clinical approach to autonomic failure in neurological disorders","volume":"10","author":"Benarroch","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0425","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ncl.2022.08.002","article-title":"Dysautonomia: diagnosis and management","volume":"41","author":"Hovaguimian","year":"2023","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neurol.2023.12.001_bib0430","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2023.12.001_bib0435","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1152\/jn.00408.2003","article-title":"Experimental autoimmune autonomic neuropathy","volume":"90","author":"Vernino","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0440","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI17429","article-title":"Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease","volume":"111","author":"Lennon","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2023.12.001_bib0445","first-page":"66","article-title":"Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments","author":"McKeon","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0450","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS euronetwork database: a european study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0455","doi-asserted-by":"crossref","first-page":"948479","DOI":"10.3389\/fimmu.2022.948479","article-title":"Characterization of cardiac bradyarrhythmia associated with LGI1-IgG autoimmune encephalitis","volume":"13","author":"Zhao-Fleming","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0460","doi-asserted-by":"crossref","first-page":"609750","DOI":"10.3389\/fneur.2021.609750","article-title":"Clinical study of autonomic dysfunction in patients with anti-NMDA receptor encephalitis","volume":"12","author":"Yan","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0465","doi-asserted-by":"crossref","first-page":"103070","DOI":"10.1016\/j.autneu.2022.103070","article-title":"Dysautonomia and related outcomes in Guillain-Barre syndrome","volume":"245","author":"Baz\u00e1n-Rodr\u00edguez","year":"2023","journal-title":"Autonom Neurosci"},{"key":"10.1016\/j.neurol.2023.12.001_bib0470","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12883-023-03162-1","article-title":"Impact of dysautonomic symptom burden on the quality of life in neuromyelitis optica spectrum disorder patients","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0475","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/B978-0-444-63432-0.00022-0","article-title":"Autoimmune autonomic disorders","volume":"133","author":"Mckeon","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0480","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/CON.0000000000000812","article-title":"Autoimmune autonomic disorders","volume":"26","author":"Vernino","year":"2020","journal-title":"Continuum (minneap minn)"},{"key":"10.1016\/j.neurol.2023.12.001_bib0485","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.12.001_bib0490","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0495","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0500","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1212\/WNL.0000000000013087","article-title":"Glial fibrillary acidic protein autoimmunity: a French cohort study","volume":"98","author":"Gravier-Dumonceau","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0505","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","article-title":"Clinical characteristics of autoimmune GFAP astrocytopathy","volume":"332","author":"Kimura","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0510","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/jnnp-2020-323226","article-title":"Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features","volume":"91","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.12.001_bib0515","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-510X(88)90037-8","article-title":"Autonomic dysfunction in Lambert-Eaton myasthenic syndrome","volume":"85","author":"Khurana","year":"1988","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2023.12.001_bib0520","doi-asserted-by":"crossref","first-page":"102403","DOI":"10.1016\/j.jaut.2020.102403","article-title":"A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy","volume":"108","author":"Nakane","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.neurol.2023.12.001_bib0525","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2008.09.005","article-title":"Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy","volume":"146","author":"Vernino","year":"2009","journal-title":"Autonom Neurosci"},{"key":"10.1016\/j.neurol.2023.12.001_bib0530","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1212\/01.wnl.0000263185.30294.61","article-title":"Autoimmune autonomic ganglionopathy","volume":"68","author":"Wang","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0535","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1523\/JNEUROSCI.1485-04.2004","article-title":"Passive transfer of autoimmune autonomic neuropathy to mice","volume":"24","author":"Vernino","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2023.12.001_bib0540","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.26018","article-title":"Multimodal biomarkers quantify recovery in autoimmune autonomic ganglionopathy","volume":"89","author":"Koay","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0545","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa051719","article-title":"Plasma exchange for primary autoimmune autonomic failure","volume":"353","author":"Schroeder","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2023.12.001_bib0550","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archneurol.2007.60","article-title":"Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy","volume":"65","author":"Gibbons","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0555","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0560","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autneu.2008.11.001","article-title":"Immunotherapy for autoimmune autonomic ganglionopathy","volume":"146","author":"Iodice","year":"2009","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.neurol.2023.12.001_bib0565","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e3181a92b52","article-title":"Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy","volume":"72","author":"Iodice","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0570","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0575","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0580","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0585","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome A review of 50 cases","volume":"111","author":"O\u2019Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.12.001_bib0590","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1212\/CON.0000000000001205","article-title":"Lambert-Eaton myasthenic syndrome and botulism","volume":"28","author":"Raja","year":"2022","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0595","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.50.1.88","article-title":"Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome","volume":"50","author":"O'Suilleabhain","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0600","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody\u00a0\u2013\u00a0associated encephalitis","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0605","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0610","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/CPJ.0000000000000978","article-title":"CASPR2-related morvan syndrome: autonomic, polysomnographic, and neuropsychological observations","volume":"11","author":"Swayang","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.neurol.2023.12.001_bib0615","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","article-title":"Neurophysiologic studies in Morvan syndrome","volume":"21","author":"Josephs","year":"2004","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0620","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.12.001_bib0625","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0630","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jamaneurol.2014.1234","article-title":"Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex\/leucine-rich, glioma inactivated 1 antibody encephalitis","volume":"71","author":"Naasan","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0635","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0640","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"146","author":"Gr\u00fcter","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.12.001_bib0645","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201603-0507OC","article-title":"Anti-N-Methyl-d-Aspartate receptor encephalitis in adult patients requiring intensive care","volume":"195","author":"de Montmollin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.neurol.2023.12.001_bib0650","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0655","series-title":"Autoimmune encephalitis and related disorders of the nervous system","author":"Dalmau","year":"2022"},{"key":"10.1016\/j.neurol.2023.12.001_bib0660","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp.51.3.436","article-title":"Abnormalities of autonomic function in the Lambert-Eaton myasthenic syndrome","volume":"51","author":"Heath","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.12.001_bib0665","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.47.3.678","article-title":"Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"47","author":"Bain","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0670","first-page":"10","article-title":"Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis","author":"Benoit","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2023.12.001_bib0675","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0680","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1212\/NXI.0000000000000086","article-title":"Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis","volume":"2","author":"Stoeck","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2023.12.001_bib0685","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2023.12.001_bib0690","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0695","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0700","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00415-018-9132-0","article-title":"Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis","volume":"266","author":"Maureille","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0705","doi-asserted-by":"crossref","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","article-title":"Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis","volume":"95","author":"Spatola","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0710","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu--associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.neurol.2023.12.001_bib0715","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.50.3.652","article-title":"Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies","volume":"50","author":"Lucchinetti","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0720","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00415-002-0706-4","article-title":"Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis\/sensory neuronopathy","volume":"249","author":"Sillevis Smitt","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0725","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0730","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.2008.158246","article-title":"Anti-Hu-associated brainstem encephalitis","volume":"80","author":"Saiz","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.12.001_bib821","doi-asserted-by":"crossref","first-page":"fcad247","DOI":"10.1093\/braincomms\/fcad247","article-title":"Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis","volume":"5","author":"Villagr\u00e1n-Garc\u00eda","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurol.2023.12.001_bib0735","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.26320","article-title":"Anti-neuronal nuclear antibody 3 autoimmunity targets dachshund homolog 1","volume":"91","author":"Zekeridou","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0740","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients: autoimmune GFAP astrocytopathy","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0745","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year","volume":"321","author":"Dubey","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0750","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-ABN.362","article-title":"037 new insight into dysautonomia in GFAP astrocytopathy","volume":"93","author":"Goh","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.12.001_bib0755","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.61.1.44","article-title":"Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody","volume":"61","author":"Sandroni","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0760","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/clinem\/dgaa247","article-title":"ROHHAD(NET) syndrome: systematic review of the clinical timeline and recommendations for diagnosis and prognosis","volume":"105","author":"Harvengt","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neurol.2023.12.001_bib0765","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10286-023-00936-y","article-title":"Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): a collaborative review of the current understanding","volume":"33","author":"Khaytin","year":"2023","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.neurol.2023.12.001_bib0770","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2023.03.003","article-title":"Neurological adverse events of immune checkpoint inhibitors: an update of clinical presentations, diagnosis, and management","author":"Farina","year":"2023","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0780","doi-asserted-by":"crossref","first-page":"fcad169","DOI":"10.1093\/braincomms\/fcad169","article-title":"Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity","volume":"5","author":"Farina","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurol.2023.12.001_bib0785","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200058","article-title":"Anti-Hu antibodies in patients with neurologic side effects of immune checkpoint inhibitors","volume":"10","author":"Farina","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2023.12.001_bib0790","doi-asserted-by":"crossref","first-page":"e1093","DOI":"10.1212\/WNL.0000000000008091","article-title":"Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies","volume":"93","author":"Dubey","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.12.001_bib0795","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1007\/s00415-023-11667-5","article-title":"Dysautonomia associated with immune checkpoint inhibitors","volume":"270","author":"Tezuka","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0800","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s10620-020-06440-x","article-title":"Gastroparesis following immune checkpoint inhibitor therapy: a case series","volume":"66","author":"Atieh","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.neurol.2023.12.001_bib0805","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1212\/CON.0000000000000815","article-title":"Autonomic history, examination, and laboratory evaluation","volume":"26","author":"Cheshire","year":"2020","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"key":"10.1016\/j.neurol.2023.12.001_bib0810","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated composite autonomic symptom score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.neurol.2023.12.001_bib0815","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2023.12.001_bib0820","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"JCO"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723011505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723011505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:47:09Z","timestamp":1758520029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723011505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":83,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0035378723011505"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2023.12.001","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}